Multi-Organ Ethanol Denervation to Treat Type 2 Diabetes Mellitus and Hypertension: 6-Month Results of an Early Feasibility Study

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Medtronic; Abbott; Boston Scientific Corporation; Amgen; Cathworks; Siemens; Philips; Recor Medical; Spectranetics; Cardiovascular Systems Incorporated; Chiesi; Opens; Zoll; Regeneron; Neurotronic; Biotronik; Bolt Medical; Magenta Medical; Canon; SoniVie; Shockwave Medical; Abiomed</li></ul>